D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Genetics D-index 57 Citations 10,930 121 World Ranking 2619 National Ranking 130

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Mutation
  • Genetics

Her primary areas of study are Genetics, Breast cancer, Mutation, Cancer and Germline mutation. Genetics is often connected to Large series in her work. Her biological study spans a wide range of topics, including Gene mutation, Cancer research and Single-nucleotide polymorphism, Genotype.

Her study in Genotype is interdisciplinary in nature, drawing from both Ovarian cancer and Allele. Her Mutation research is multidisciplinary, relying on both Genetic testing and Exon. Her work deals with themes such as Gene rearrangement and Coding region, which intersect with Frameshift mutation.

Her most cited work include:

  • Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. (429 citations)
  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (406 citations)
  • Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk (344 citations)

What are the main themes of her work throughout her whole career to date?

Sylvie Mazoyer mainly investigates Genetics, Breast cancer, Gene, Ovarian cancer and Cancer research. Her study in Exon, Mutation, Allele, Germline mutation and Locus is carried out as part of her studies in Genetics. She combines subjects such as Gene rearrangement and Genetic testing with her study of Mutation.

Her Breast cancer research includes elements of Genome-wide association study, Genotype, Single-nucleotide polymorphism and Oncology. Her studies deal with areas such as Gene mutation and Haplotype as well as Single-nucleotide polymorphism. In her research, Nonsense-mediated decay is intimately related to Molecular biology, which falls under the overarching field of Gene.

She most often published in these fields:

  • Genetics (71.54%)
  • Breast cancer (48.46%)
  • Gene (26.92%)

What were the highlights of her more recent work (between 2014-2021)?

  • Genetics (71.54%)
  • Breast cancer (48.46%)
  • Genome-wide association study (17.69%)

In recent papers she was focusing on the following fields of study:

Her primary scientific interests are in Genetics, Breast cancer, Genome-wide association study, Ovarian cancer and Oncology. Her Locus, Allele, Gene, Single-nucleotide polymorphism and Genetic association investigations are all subjects of Genetics research. In Locus, Sylvie Mazoyer works on issues like Genotype, which are connected to Cancer research.

Her research in Breast cancer intersects with topics in Mutation, Germline mutation and Genetic testing. Her study in the fields of BRCA2 Mutation under the domain of Ovarian cancer overlaps with other disciplines such as Medical research. Sylvie Mazoyer has researched Oncology in several fields, including Pancreatic cancer, Genetic predisposition, Internal medicine, Case-control study and Prostate cancer.

Between 2014 and 2021, her most popular works were:

  • Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. (247 citations)
  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer (155 citations)
  • Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. (149 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Mutation
  • Genetics

Breast cancer, Genome-wide association study, Genetics, Internal medicine and Oncology are her primary areas of study. Her Breast cancer study incorporates themes from Mutation, Cancer research, Risk factor and Medical genetics. The various areas that Sylvie Mazoyer examines in her Mutation study include Cancer, Exon skipping and FANCM.

The Cancer research study combines topics in areas such as Genotyping, Serous fluid, Allele and Age of onset. Her Risk factor research includes themes of Single-nucleotide polymorphism and Gene mutation. Sylvie Mazoyer is studying Locus, which is a component of Genetics.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.

S. A. Gayther;W. Warren;S. Mazoyer;P. A. Russell.
Nature Genetics (1995)

608 Citations

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)

604 Citations

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Timothy R. Rebbeck;Nandita Mitra;Fei Wan;Olga M. Sinilnikova.
JAMA (2015)

427 Citations

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

Antonis C. Antoniou;Xianshu Wang;Zachary S. Fredericksen;Lesley McGuffog.
Nature Genetics (2010)

394 Citations

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

Antonis C. Antoniou;Antonis C. Antoniou;Amanda B. Spurdle;Amanda B. Spurdle;Olga M. Sinilnikova;Olga M. Sinilnikova;Sue Healey;Sue Healey.
American Journal of Human Genetics (2008)

360 Citations

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Fergus J. Couch;Xianshu Wang;Lesley McGuffog;Andrew Lee.
PLOS Genetics (2013)

352 Citations

Down-regulation of BRCA1 Expression by miR-146a and miR-146b-5p in Triple Negative Sporadic Breast Cancers

Amandine I Garcia;Monique Buisson;Pascale Bertrand;Ruth Rimokh.
Embo Molecular Medicine (2011)

331 Citations

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study

Susan L. Neuhausen;Sylvie Mazoyer;Lori Friedman;Michael Stratton.
American Journal of Human Genetics (1998)

314 Citations

The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons

Laure Perrin-Vidoz;Olga M. Sinilnikova;Dominique Stoppa-Lyonnet;Gilbert M. Lenoir.
Human Molecular Genetics (2002)

292 Citations

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar.
Nature Genetics (2017)

269 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sylvie Mazoyer

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 189

Douglas F. Easton

Douglas F. Easton

University of Trieste

Publications: 161

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 146

Melissa C. Southey

Melissa C. Southey

Monash University

Publications: 133

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 129

Georgia Chenevix-Trench

Georgia Chenevix-Trench

QIMR Berghofer Medical Research Institute

Publications: 126

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 123

Dominique Stoppa-Lyonnet

Dominique Stoppa-Lyonnet

Institute Curie

Publications: 122

Fergus J. Couch

Fergus J. Couch

Mayo Clinic

Publications: 113

Hiltrud Brauch

Hiltrud Brauch

German Cancer Research Center

Publications: 108

Heli Nevanlinna

Heli Nevanlinna

University of Helsinki

Publications: 106

Irene L. Andrulis

Irene L. Andrulis

University of Toronto

Publications: 99

Anna Jakubowska

Anna Jakubowska

Pomeranian Medical University

Publications: 96

John L. Hopper

John L. Hopper

University of Melbourne

Publications: 95

Jan Lubinski

Jan Lubinski

Pomeranian Medical University

Publications: 93

Javier Benitez

Javier Benitez

Instituto de Salud Carlos III

Publications: 89

Trending Scientists

Matthias Felleisen

Matthias Felleisen

Northeastern University

Michel Valstar

Michel Valstar

University of Nottingham

Guy Lapalme

Guy Lapalme

University of Montreal

Manfred Zeller

Manfred Zeller

University of Hohenheim

Terry Wall

Terry Wall

University of Newcastle Australia

Alexander Grüneis

Alexander Grüneis

University of Cologne

Colm O'Dwyer

Colm O'Dwyer

University College Cork

George R. Uhl

George R. Uhl

University of Maryland, Baltimore

Manuel Garber

Manuel Garber

University of Massachusetts Medical School

Thomas W. Hennessy

Thomas W. Hennessy

Centers for Disease Control and Prevention

Jean-François Ghienne

Jean-François Ghienne

University of Strasbourg

Nancy F. Glenn

Nancy F. Glenn

Boise State University

Stuart W. Krasner

Stuart W. Krasner

Metropolitan Water District of Southern California

David K. Bilkey

David K. Bilkey

University of Otago

Dan Jones

Dan Jones

The Ohio State University

Richard Matzopoulos

Richard Matzopoulos

South African Medical Research Council

Something went wrong. Please try again later.